The Most Innovative Ways to Use CRISPR | OpenMind
CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes - YouTube
Stem Cells and the Search For a Type 1 Diabetes Cure
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination - eBioMedicine
Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
CRISPR, ViaCyte begin dosing in phase 1 trial of gene-edited therapy for type 1 diabetes | Seeking Alpha
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Forscher heilen Diabetes bei Mäusen mit genkorrigierten menschlichen...
Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines - ScienceDirect
CRISPR Therapeutics and ViaCyte, Inc. Announce First
Strategies for durable β cell replacement in type 1 diabetes | Science
News: First CRISPR Therapy for Type 1 Diabetes Set to Enter Clinical Trial - CRISPR Medicine
ActoBio's Cheese-Producing Bacteria Could Reverse Type 1 Diabetes
CRISPR/Cas9 deletions induce adverse on-target genomic effects
Can CRISPR Therapeutics (CRSP) and ViaCyte CURE Type 1 Diabetes? | VCTX210 - YouTube
CRISPR for Type 1 & 2 Diabetes Identification and Treatment | IDT
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review | PLOS ONE
CRISPR-Cas9 successfully reverses obesity in mice
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes | Nature Metabolism
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
